DNA 'reverse' vaccine reduces levels of immune cells believed responsible for Type 1 diabetes
A clinical trial of a vaccine, led by Stanford University School of Medicine researchers and designed to combat type-1 diabetes, has delivered initially promising results, suggesting that it may selectively counter the errant ...
Jun 26, 2013
0
0